<DOC>
	<DOCNO>NCT01121536</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability long term ( 6 month ) armodafinil treatment adjunctive therapy mood-stabilizing medication adult bipolar I disorder .</brief_summary>
	<brief_title>Extension Study Safety Efficacy Armodafinil Treatment Adjunctive Therapy Adults With Major Depression Associated With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Key The patient complete 8 week treatment Cephalonsponsored Phase 3 , doubleblind study armodafinil treatment patient major depression associate bipolar I disorder . The patient meet criterion enrollment previous doubleblind study , opinion investigator , need continue treatment depression . During previous doubleblind study , patient must take 1 ( 2 ) follow protocolallowed mood stabilizer : lithium ; valproic acid ; olanzapine ; quetiapine ; aripiprazole ; lamotrigine ; risperidone ; ziprasidone , ( take combination lithium , valproic acid , lamotrigine ) . The following criterion must also meet : 1 . The mood stabilizer must take oral formulation , exception risperidone , either oral longacting injection formulation . 2 . The patient may take 2 protocolallowed mood stabilizer 1 drug lithium , valproic acid , lamotrigine . 3 . The patient must judge investigator compliant treatment mood stabilizer ( ) . 4 . The patient must willing continue treatment protocolallowed mood stabilizer ( ) dosages consider appropriate investigator . The patient Young Mania Rating Scale ( YMRS ) total score 14 less enrollment visit . Patients YMRS score 12 14 must discuss medical monitor determine suitability enrollment . Key The patient Axis I Axis II disorder apart bipolar I disorder become primary focus treatment doubleblind study . The patient psychotic symptom psychosis doubleblind study . The patient current active suicidal ideation , imminent risk self harm , history significant suicidal ideation suicide attempt time past cause concern present . The patient meet criterion alcohol substance abuse dependence ( exception nicotine dependence ) doubleblind study . The patient history homicidal ideation significant aggression currently homicidal significant aggressive ideation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Bipolar I Disorder</keyword>
</DOC>